MRUS
Merus BV
NASDAQ: MRUS · HEALTHCARE · BIOTECHNOLOGY
$90.00
+0.00% today
Updated 2025-12-30
Market cap
$6.83B
P/E ratio
—
P/S ratio
120.59x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$33 – $97
Volume
1.3M
Merus BV (MRUS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.62M | $-17.74M | $-25.18M | $-27.06M | $-44.88M | $-46.33M | $-63.05M | $-79.90M | $-59.63M | $-149.90M | $-142.21M | $-185.84M |
| Capital expenditures | $114612.00 | $190913.00 | $112610.00 | $521644.00 | $868584.00 | $4.21M | $2.60M | $1.29M | $870000.00 | $7.64M | $3.98M | $1.67M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — | — | — |
| Free cash flow | $-9.73M | $-17.93M | $-25.29M | $-27.59M | $-45.75M | $-50.53M | $-65.65M | $-81.19M | $-60.50M | $-157.54M | $-146.19M | $-187.50M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |